Ryan A. Bragg
AstraZeneca
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ryan A. Bragg.
Organic Letters | 2010
Philip A. Woods; Louis C. Morrill; Tomas Lebl; Alexandra M. Z. Slawin; Ryan A. Bragg; Andrew D. Smith
Isothiourea DHPB promotes the diastereoselective C-acylation of silyl ketene acetals with anhydrides or benzoyl fluoride, giving 3-acyl-3-aryl or 3-acyl-3-alkylfuranones in excellent yields and stereoselectivities (up to 99:1 dr).
Chemistry: A European Journal | 2011
Philip A. Woods; Louis C. Morrill; Ryan A. Bragg; Andrew D. Smith
Screening of a range of chiral isothioureas and acyl donors to promote the asymmetric C-acylation of silyl ketene acetals indicates that C(2)-aryl-dihydropyrimidobenzothiazole-derived isothioureas and propionic anhydride give optimal reactivity and enantioselectivity in this process. Under optimised conditions 3-acyl-3-aryl or 3-acyl-3-alkylfuranones are prepared in good yields and moderate to excellent enantioselectivities (up to 98% ee; ee=enantiomeric excess).
Bioorganic & Medicinal Chemistry Letters | 2015
Charles S. Elmore; Ryan A. Bragg
As Medicinal Chemists are responsible for the synthesis and optimization of compounds, they often provide intermediates for use by isotope chemistry. Nevertheless, there is generally an incomplete understanding of the critical factors involved in the labeling of compounds. The remit of an Isotope Chemistry group varies from company to company, but often includes the synthesis of compounds labeled with radioisotopes, especially H-3 and C-14 and occasionally I-125, and stable isotopes, especially H-2, C-13, and N-15. Often the remit will also include the synthesis of drug metabolites. The methods used to prepare radiolabeled compounds by Isotope Chemists have been reviewed relatively recently. However, the organization and utilization of Isotope Chemistry has not been discussed recently and will be reviewed herein.
Chemistry: A European Journal | 2012
Caroline Joannesse; Craig P. Johnston; Louis C. Morrill; Philip A. Woods; Madeleine Kieffer; Tobias A. Nigst; Herbert Mayr; Tomas Lebl; Douglas Philp; Ryan A. Bragg; Andrew D. Smith
The structural motif within a series of tetrahydropyrimidine-based isothioureas necessary for generating high asymmetric induction in the asymmetric Steglich rearrangement of oxazolyl carbonates is fully explored, with crossover and dynamic (19)F NMR experiments used to develop a mechanistic understanding of this transformation.
Journal of Labelled Compounds and Radiopharmaceuticals | 2016
Ryan A. Bragg; Nick Bushby; Cecilia Ericsson; Lee P. Kingston; Hailong Ji; Charles S. Elmore
As part of a Medicinal Chemistry program aimed at developing an orally bioavailable selective estrogen receptor degrader, a number of tritium, carbon-14, and stable isotope labelled (E)-3-[4-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl]prop-2-enoic acids were required. This paper discusses 5 synthetic approaches to this compound class.
Journal of Labelled Compounds and Radiopharmaceuticals | 2017
Paul H. Allen; Ryan A. Bragg; Moya Caffrey; Cecilia Ericsson; Michael J. Hickey; Lee P. Kingston; Charles S. Elmore
As part of a medicinal chemistry program aimed at developing a highly potent and selective cathepsin C inhibitor, tritium, carbon-14, and stable isotope-labeled materials were required. The synthesis of tritium-labeled methanesulfonate 5 was achieved via catalytic tritiolysis of a chloro precursor, albeit at a low radiochemical purity of 67%. Tritium-labeled AZD5248 was prepared via a 3-stage synthesis, utilizing amide-directed hydrogen isotope exchange. Carbon-14 and stable isotope-labeled AZD5248 were successfully prepared through modifications of the medicinal chemistry synthetic route, enabling the use of available labeled intermediates.
Journal of Labelled Compounds and Radiopharmaceuticals | 2018
Ryan A. Bragg; Malvika Sardana; Markus Artelsmair; Charles S. Elmore
Carboxylations are an important method for the incorporation of isotopically labeled 14CO2 into molecules. This manuscript will review labeled carboxylations since 2010 and will present a perspective on the potential of recent unlabeled methodology for labeled carboxylations. The perspective portion of the manuscript is broken into 3 major sections based on product type, arylcarboxylic acids, benzylcarboxylic acids, and alkyl carboxylic acids, and each of those sections is further subdivided by substrate.
Journal of Labelled Compounds and Radiopharmaceuticals | 2017
Kate Ellis‐Sawyer; Ryan A. Bragg; Nick Bushby; Charles S. Elmore; Michael J. Hickey
The aryl methyl group is found in many drug-like compounds, but there are limited ways of preparing compounds with an isotope label in this methyl position. The process of cyanation of an aryl halide followed by complete reduction of the nitrile to a methyl group was investigated as a route for preparing stable and radiolabelled isotopologues of drug-like compounds. Using this methodology, carbon-13, deuterium, carbon-14, and tritium labelled isotopologues of the nonsteroidal anti-inflammatory drug tolmetin were produced, as well as carbon-13, deuterium, and carbon-14 labelled isotopologues of another nonsteroidal anti-inflammatory drug, celecoxib. The radiolabelled compounds were produced at high specific activity and the stable isotope labelled compounds with high incorporation making them suitable for use as internal standards in mass spectrometry assays. This approach provides a common synthetic route to multiple isotopologues of compounds using inexpensive and readily available labelled starting materials.
Organic and Biomolecular Chemistry | 2011
Dorine Belmessieri; Caroline Joannesse; Philip A. Woods; Callum MacGregor; Caroline Jones; Craig D. Campbell; Craig P. Johnston; Nicolas Duguet; Carmen Concellón; Ryan A. Bragg; Andrew D. Smith
Bioorganic & Medicinal Chemistry Letters | 2003
Stephen J. Davies; R.Paul Beckett; Ryan A. Bragg; John M. Clements; Sheila Doel; Christine Grew; Steven B. Launchbury; Gemma M. Perkins; Lisa M. Pratt; Helen Katherine Smith; Zoe Marie Spavold; S.Wayne Thomas; Richard S. Todd; Mark Whittaker